RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT06449274

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06449274
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06449274. Randomized; single masking; primary purpose treatment. Start 2024-06-25 (actual); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial
Condition
Acute Coronary Syndrome (ACS)
Intervention (Device)
Drug-coated balloon
Intervention (Drug)
Guideline-directed medical treatment
Lead sponsor
Harbin Medical University (class: other)
Collaborator
Shanghai Shenqi Medical Technology Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06449274
Content hash
7fce55c0a1b53e848684c614ed563024e00c2880e8ac9995d14b46f7745653f3